Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Axis NIFTY Healthcare ETF Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.00 |
Equity |
99.90 |
Trep |
0.10 |
|
|
Concentration Analysis |
Top 5 Holdings |
55.10% |
Top 10 Holdings |
78.83% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
78.0 |
Healthcare |
21.9 |
Cash |
0.1 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.33 |
PE Ratio |
36.45 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
19.65 |
DIVI LABORATORIES LTD |
9.12 |
Max Healthcare Institute Limited |
9.08 |
Cipla Limited |
8.96 |
Dr Reddys Laboratories Limited |
8.29 |
Apollo Hospitals Enterprise Limited |
7.55 |
Lupin Limited |
5.14 |
Fortis Health Care Ltd |
3.94 |
Torrent Pharmaceuticals Limited |
3.61 |
Aurobindo Pharma Limited |
3.49 |
Mankind Pharma Limited |
2.96 |
Alkem Laboratories Limited |
2.94 |
Laurus Labs Limited |
2.59 |
Zydus Lifesciences Limited |
2.52 |
Glenmark Pharmaceuticals Limited |
2.38 |
IPCA Laboratories Limited |
2.15 |
Abbott India Limited |
1.72 |
Biocon Limited |
1.64 |
Syngene International Limited |
1.33 |
Granules India Limited |
0.84 |
Clearing Corporation of India Ltd |
0.10 |
Net Current Assets |
0.03 |
Net Receivables / (Payables) |
-0.03 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|